Can anyone guide that how many countries or medical practitioners have adopted the research SYSUCC-001 “Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment”.
We live in Pakistan and my wife’s oncologist has advised us to go with this research. She was diagnosed with triple-negative breast cancer and has shown a complete pathological response to chemo and there was no residual disease left after surgery.